Patent ID: 7101901
Filing Date: 2006-09-05
Classification: A61K,A61P,C07D

Abstract:
1. A method of treating neurodegenerative diseases selected from the group consisting of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease, comprising administering (2R,4R)-2-methylthiazolidine-2,4-dicarboxylic acid, (2S,4R)-2-methylthiazolidine-2,4-dicarboxylic acid and/or (2RS,4R)-2-methylthiazolidine-2,4-dicarboxylic acid as well as their salts to a patient in need thereof.